Trial Profile
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based in Body Surface Area
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis
- Focus Pharmacokinetics
- 05 Nov 2015 Results published in the Pediatric Infectious Disease Journal
- 04 Mar 2015 New trial record